Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101679156A details a novel decarboxylation process for fluoroalkyl alcohols using amine catalysts, offering high selectivity and cost-effective manufacturing solutions.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN114277006A reveals a novel alcohol dehydrogenase for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant supply chain and cost advantages.
Patent CN114751872B reveals novel Column[5]arene NHC catalyst enabling mild Stetter reactions. Delivers high purity, operational simplicity, and supply chain reliability for global chemical procurement.
Patent CN117051052A reveals high-purity NEB-8 synthesis via MrADH. Offers supply chain reliability and significant cost reduction in pharmaceutical intermediate manufacturing processes.
Patent CN117737149A details enzymatic synthesis for high-purity S-vitronectin. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113200932B reveals a novel TDAC-catalyzed route for oxazolidinone synthesis, offering metal-free purity and chiral retention for pharmaceutical intermediates.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Discover a novel water-based Huisgen cycloaddition using pullulan triazole/CuCl. Achieves high yields, catalyst reusability, and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.
Advanced synthesis of ornithine phytosterol ester hydrochloride via patent CN108912201B. Enhances bioavailability and solubility for food and pharma applications with over 99 percent purity.
Patent CN106414375B reveals advanced Ru-SNP catalysts for ester hydrogenation. Discover cost reduction in synthetic flavors & fragrances manufacturing and high-purity supply solutions.
Patent CN110292948B reveals a metal-free carboxylation method using imidazole salts, offering safer atmospheric pressure synthesis for pharmaceutical intermediates.
Patent CN104892575A details asymmetric oxidation for high-purity PPI intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106187982A reveals green ionic liquid catalysis for high-purity xanthenedione. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.